LGM
QTTB icon

Logos Global Management’s Q32 Bio QTTB Stock Holding History

Logos Global Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
+800,000
New +$6.68M 0.44% 48

Other funds holding QTTB

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Logos Global Management's QTTB Position: Q2 2026 in Review

Logos Global Management opened a new position in Q32 Bio (QTTB) in Q2 2026: 800,000 shares worth $10.2M. The stake represents 0.44% of the portfolio and ranks #48 among its holdings.

49 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Logos Global Management held 800,000 shares of Q32 Bio worth $10.2M as of Q2 2026.
  • Q32 Bio was a new Logos Global Management position in Q2 2026.
  • Q32 Bio made up 0.44% of Logos Global Management's portfolio in Q2 2026, its #48 holding.
  • 49 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Logos Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.